
This review explores the effectiveness and safety of cancer chemotherapy in older individuals and outlines potential guidelines for the management of these zzso Cancer chemotherapy appears less effective in three zzso of older zzso acute zzso zzso large cell lymphoma, and zzso zzso of the zzso In the case of acute zzso zzso a higher prevalence of zzso expression and involvement of the zzso zzso stem cells in the zzso process contribute to chemotherapy zzso zzso zzso zzso and peripheral and central zzso are more common and more severe in older zzso This toxicity results from the increased vulnerability of target zzso and delayed zzso of zzso zzso zzso The complications of chemotherapy may be ameliorated by zzso the doses of drugs according to the patient's zzso zzso by using antidotes to drug zzso and by the early diagnosis and timely management of therapeutic zzso A comprehensive assessment of the older person with cancer allows clinicians to predict the benefits and risks of cancer chemotherapy in individual zzso 

